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INTRODUCTION
Figure 1
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Primary Hepatic Leiomyosarcoma (PHL) is a rare malignant tumor arising from 
smooth muscle cells of either vascular, biliary, or ligamentous origin. Underlying 
etiologic factors are unknown, with few associations described in the literature. 
The median age of diagnosis is 58 years.1 Diagnosis is often delayed due to 
the tumor causing nonspecific symptoms and often remaining asymptomatic 
until mass effect is produced. Once PHL presents itself, it is still challenging to 
diagnose due to the non-specific nature of symptoms and lack of serological or 
tumor markers.2
This case represents one of thirty cases reported in the literature and is 
consistent with the presentation and disease course described by previous case 
reports in the literature, yet with an interesting difference in the patient’s history.1
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CASE
A 60-year-old male with extensive travel history to developing countries initially 
presented to a medical facility in Micronesia with bilateral lower extremity 
edema, dyspnea, fever, and fatigue  attributed to an upper respiratory infection. 
He ultimately underwent CT of the abdomen and pelvis in Guam, which revealed 
a 13.6 x 16.8cm right hepatic lobe mass with obstruction of the IVC. He left 
Guam without a definitive diagnosis and presented to our institution two days 
later.  
On arrival, he complained of non-specific symptoms such as dyspnea, malaise, 
weight loss, fever and lower extremity edema. Physical exam was notable for 
abdominal distention and palpable organomegaly, bilateral pitting lower extremity 
edema to the knee with a desquamating rash on all extremities. Initial vitals: 
BP: 115/78  Pulse: 110 Temp: 100.5F Respiration Rate: 20
Due to leukocytosis, fever, and recent travel to developing areas with known 
exposures to unclean water, animals, and work as a plumber, the initial leading 
diagnoses were largely infectious etiologies.  Hepatocellular carcinoma remained 
lower on the differential as he had no history of cirrhosis, hepatitis C, or alcohol 
abuse.
LAB DATA AND IMAGING
A repeat CT scan and an MRI were performed at our institution 
(Figure 1 and Figure 2).  Due to the suspicion for hepatic abscess, 
CT guided drainage was ordered. However, given the solid nature 
of the lesion, a CT guided liver biopsy demonstrated nonspecific 
fibrotic and infarcted liver parenchyma. As infectious workup and 
tumor markers were unrevealing, a repeat biopsy was obtained. 
This revealed a poorly differentiated carcinoma without a definitive 
primary site. Further imaging studies to assess for additional lesions 
and metastatic disease were unrevealing.
The patient underwent open right hepatic lobectomy with resection 
of tumor and repair of the IVC with Surgical Oncology and 
Cardiothoracic Surgery. The patient tolerated surgery remarkably 
well and was subsequently discharged home with plans for potential 
adjuvant treatment. Surgical pathology, reviewed by an outside 
institution, demonstrated epithelioid elements with regions of smooth 
muscle morphology supporting the impression of high-grade PHL 
(Figure 3).  
The patient underwent a trial of chemotherapy, but ultimately 
succumbed to the malignancy within a year. 
Figure 2
DISCUSSION
PHL is a rare malignant tumor.  Most studies are limited to case reports or case series.1 
In our patient, with an extensive travel history, yet low risk for cirrhosis or hepatocellular 
carcinoma, the differential diagnosis initially pointed to infectious disease. Hepatocellular 
carcinoma and hyatid disease are often initial diagnoses in other cases eventually 
diagnosed with PHL. PHL is especially difficult to diagnose because of the non-specific 
symptoms or lab work, including lack of established tumor makers or serological markers.2 
The rarity of the disease makes clinical judgment and standard of care a challenge.1 
Until recently, surgeries involving the IVC in primary or metastatic liver tumors were 
considered too complex due to high-risk morbidity and mortality.4,5 Tumors arising from 
the hepatic veins are more prone to develop Budd-Chiari syndrome and have a worse 
prognosis.1 Yet, surgery offers the only chance for cure.6 Unfortunately, surgical removal 
does not guarantee long-term survival. Alternative therapies, such as radiotherapy and 
chemotherapy often proved insufficient.5 
CONCLUSIONS
•  Primary hepatic leiomyosarcoma is an exceedingly rare liver tumor with a poor 
prognosis. The literature on this condition is limited to mostly case reports and series.
•  The characteristically delayed presentation due to nonspecific symptoms and the 
challenges with diagnostic and therapeutic modalities all contribute to difficulties with 
diagnosis and treatment.
•  Most PHL cases are thought to arise from the wall of major blood vessels. It is likely that 
our patient’s tumor originated from a venous structure. 
•  Surgical resection is the management of choice with the role of chemotherapy and 
radiation not well defined.
•  Although rare, primary hepatic leiomyosarcoma should remain on the differential of 
hepatic masses in patients without the classic risk factors for hepatocellular carcinoma.  
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1SELECT Program University of South Florida Morsani College of Medicine, Tampa, FL, 2Department of Medicine, Lehigh Valley Health Network, Allentown, PA
Primary Hepatic Leiomyosarcoma Presenting as a Budd-Chiari-like Syndrome
Jessica Watson1, Carolyn Hanna2, Ross Biggs2, and Matthew Sullivan2
